Please login to the form below

Not currently logged in
Email:
Password:

Fluarix Quadrivalent

This page shows the latest Fluarix Quadrivalent news and features for those working in and with pharma, biotech and healthcare.

GSK gets OK for second quadrivalent flu vaccine in US

GSK gets OK for second quadrivalent flu vaccine in US

GSK joined the club when its Fluarix Quadrivalent was approved by the FDA last December, and since then Sanofi has also been given a green light for its Fluzone Quadrivalent, giving ... This year the WHO also made recommendations for quadrivalent

Latest news

  • FDA approves Sanofi's four-in-one flu vaccine FDA approves Sanofi's four-in-one flu vaccine

    It becomes the third major four-strain influenza vaccine approved in the US following FDA backing for AstraZeneca's FluMist Quadrivalent in March 2012 and GlaxoSmithKline's (GSK) Fluarix Quadrivalent nine ... which is approved in people aged two to 49,

  • GSK’s four-strain flu vaccine approved in Germany and UK GSK’s four-strain flu vaccine approved in Germany and UK

    Will be sold as Influsplit Tetra in Germany and Fluarix Tetra in the UK. ... GSK launched its four-strain version in the US last December under the Fluarix Quadrivalent name, and with AstraZeneca/Medimmune's FluMist Quadrivalent already on the market,

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

WHITE PAPER: The increasing importance of clinical trial marketing advertising in patient recruitment
Learn why advertising is more important than ever in clinical studies...
The 'winner takes all' pricing game
Tendering has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s....
Early diagnosis underpins NHS cancer strategy
Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan...

Infographics